Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 112

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Busulfan Conditioning Enhances Engraftment of Hematopoietic Donor-derived Cells in the Brain Compared With Irradiation

Wilkinson, Fiona L, Sergijenko, Ana, Langford-Smith, Kia J, Malinowska, Marcela, Wynn, Rob F, Bigger, Brian W·2013·Molecular Therapy

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mt.2013.29

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Quantification of total, resting, and activated donor-derived microglia in the brains of busulfan- and irradiation-conditioned transplant recipients. ( a ) (i) GFP + bone marrow (BM) was delivered via the tail vein into mice that had undergone full myeloablative conditioning, using either busulfan (Bu) or irradiation (Ir), to investigate the level of brain engraftment after BMT. (ii) Peripheral blood donor cell chimerism (GFP) was significantly lower in busulfan-conditioned recipients compared with the irradiated (* P < 0.0001) 2 weeks after BMT with full chimerism reached in both groups by 7 weeks ( n = 6/group). (iii) 6 to 9 months after BMT, the number of GFP + cells were counted from six coronal sections of brain taken from Bregma 0.98, 0.26, -0.46, -1.18, -1.94, and -2.62 mm (1 to 6; n = 6 mice/group). ( b ) GFP + cells (brown; nuclei stained blue) were counted according to their morphology; ( c ) ramified or amoeboid (bar = 50 μm) in both the short (2 weeks) and long term (6-9 months) after BMT. The overall number of GFP + cells and number of ramified donor-derived GFP + cells in busulfan-conditioned brain was significantly higher than irradiated brain at both timepoints ( P < 0.03). Irradiated brain contained significantly more activated amoeboid GFP + donor-derived cells long term after BMT ( P < 0.001). ( d ) Distribution of GFP + cells (green) in the primary motor, somatosensory and parietal areas of the cerebral cortex and the submedial and ventromedial thalamic nucleus of irradiated and busulfan-conditioned brains taken from the same area of Bregma (-0.46 mm) were visualized using confocal microscopy (bar = 100 μm). Arrows show ramified cells and arrow heads show amoeboid GFP + cells. Ramified GFP + cells were more likely to be detected in the submedial and ventromedial thalamic nucleus. ( e ) Significantly more ramified GFP + cells were detected in all regions of busulfan-conditioned brain (cerebral cortex, hippocampus, and the rest of the brain; P = 0.05) except in the white matter, long term after BMT. By contrast, significantly more amoeboid GFP + cells were detected in all regions of irradiated brain ( P < 0.001) except in the white matter. Error bars represent the SEM and P values are from Student's t -test ( b and e ) or one-way analysis of variance with Tukey's multicomparison test ( a (ii)). BMT, bone marrow transplantation; GFP, green fluorescent protein.
Figure 1 Quantification of total, resting, and activated donor-derived microglia in the brains of busulfan- and irradiation-conditioned transplant recipients. ( a ) (i) GFP + bone marrow (BM) was delivered via the tail vein into mice that had undergone full myeloablative conditioning, using either busulfan (Bu) or irradiation (Ir), to investigate the level of brain engraftment after BMT. (ii) Peripheral blood donor cell chimerism (GFP) was significantly lower in busulfan-conditioned recipients compared with the irradiated (* P < 0.0001) 2 weeks after BMT with full chimerism reached in both groups by 7 weeks ( n = 6/group). (iii) 6 to 9 months after BMT, the number of GFP + cells were counted from six coronal sections of brain taken from Bregma 0.98, 0.26, -0.46, -1.18, -1.94, and -2.62 mm (1 to 6; n = 6 mice/group). ( b ) GFP + cells (brown; nuclei stained blue) were counted according to their morphology; ( c ) ramified or amoeboid (bar = 50 μm) in both the short (2 weeks) and long term (6-9 months) after BMT. The overall number of GFP + cells and number of ramified donor-derived GFP + cells in busulfan-conditioned brain was significantly higher than irradiated brain at both timepoints ( P < 0.03). Irradiated brain contained significantly more activated amoeboid GFP + donor-derived cells long term after BMT ( P < 0.001). ( d ) Distribution of GFP + cells (green) in the primary motor, somatosensory and parietal areas of the cerebral cortex and the submedial and ventromedial thalamic nucleus of irradiated and busulfan-conditioned brains taken from the same area of Bregma (-0.46 mm) were visualized using confocal microscopy (bar = 100 μm). Arrows show ramified cells and arrow heads show amoeboid GFP + cells. Ramified GFP + cells were more likely to be detected in the submedial and ventromedial thalamic nucleus. ( e ) Significantly more ramified GFP + cells were detected in all regions of busulfan-conditioned brain (cerebral cortex, hippocampus, and the rest of the brain; P = 0.05) except in the white matter, long term after BMT. By contrast, significantly more amoeboid GFP + cells were detected in all regions of irradiated brain ( P < 0.001) except in the white matter. Error bars represent the SEM and P values are from Student's t -test ( b and e ) or one-way analysis of variance with Tukey's multicomparison test ( a (ii)). BMT, bone marrow transplantation; GFP, green fluorescent protein.CC-BY-NC-ND · From the PDF
Figure 2 Quantification of total, resting, and activated Iba-1 + microglia in the brains of busulfan- and irradiation-conditioned transplant recipients. ( a ) The number of Iba-1 + cells were counted in the adjacent set of six brain sections, also according to their morphology, either ramified or amoeboid ( n = 6/group). A significant difference in the overall number and number of ramified Iba-1 + cells was detected in the brains of irradiated (Ir) recipients in the short-term period after BMT ( P < 0.01) compared with the busulfan-conditioned (Bu) recipients. No significant differences in Iba-1 + cells were detected in recipients long term after BMT. ( b ) Colocalization of GFP (green) and Iba-1 (red; nuclei, blue) in recipients in both the short and long term after BMT at high magnification (bar = 20 μm) visualized using confocal microscopy. Error bars represent the SEM and P values are from Student's t -test. BMT, bone marrow transplantation; GFP, green fluorescent protein.
Figure 2 Quantification of total, resting, and activated Iba-1 + microglia in the brains of busulfan- and irradiation-conditioned transplant recipients. ( a ) The number of Iba-1 + cells were counted in the adjacent set of six brain sections, also according to their morphology, either ramified or amoeboid ( n = 6/group). A significant difference in the overall number and number of ramified Iba-1 + cells was detected in the brains of irradiated (Ir) recipients in the short-term period after BMT ( P < 0.01) compared with the busulfan-conditioned (Bu) recipients. No significant differences in Iba-1 + cells were detected in recipients long term after BMT. ( b ) Colocalization of GFP (green) and Iba-1 (red; nuclei, blue) in recipients in both the short and long term after BMT at high magnification (bar = 20 μm) visualized using confocal microscopy. Error bars represent the SEM and P values are from Student's t -test. BMT, bone marrow transplantation; GFP, green fluorescent protein.CC-BY-NC-ND · From the PDF
Image 3
CC-BY-NC-ND · From the PDF
Figure 4 Quantification of numbers of proliferating Ki67 + cells in the brains of busulfan- and irradiation-conditioned transplant recipients. ( a ) To examine the level of proliferation after BMT, Ki67 + cells were counted in brain sections taken from Bregma 0.26, -0.46, -1.18, and -1.94 mm (2 to 5; Figure 1a ; (iii)) both in the short ( n = 4/group) and long term after BMT ( n = 3-4/group; one value was excluded as it was >10 SDs outside of the mean). Proliferation was significantly higher in irradiated (Ir) brain in the long-term group compared with the busulfan-conditioned (Bu) brain. ( b ) (i and ii) Ki67 + proliferating cells were identified as Iba-1 + and ( c ) (i and ii) GFAP - using colocalization immunohistochemistry. Brain sections were visualized using confocal microscopy at low ( b (i) and c (i); bar = 100 μm) and higher power ( b (ii) bar = 20 μm and c (ii) bar = 40 μm). The boxed areas in b (i) and c (i) are magnified in b (ii) and c (ii) respectively. Error bars represent the SEM and P values are from Student's t -test. BMT, bone marrow transplantation.
Figure 4 Quantification of numbers of proliferating Ki67 + cells in the brains of busulfan- and irradiation-conditioned transplant recipients. ( a ) To examine the level of proliferation after BMT, Ki67 + cells were counted in brain sections taken from Bregma 0.26, -0.46, -1.18, and -1.94 mm (2 to 5; Figure 1a ; (iii)) both in the short ( n = 4/group) and long term after BMT ( n = 3-4/group; one value was excluded as it was >10 SDs outside of the mean). Proliferation was significantly higher in irradiated (Ir) brain in the long-term group compared with the busulfan-conditioned (Bu) brain. ( b ) (i and ii) Ki67 + proliferating cells were identified as Iba-1 + and ( c ) (i and ii) GFAP - using colocalization immunohistochemistry. Brain sections were visualized using confocal microscopy at low ( b (i) and c (i); bar = 100 μm) and higher power ( b (ii) bar = 20 μm and c (ii) bar = 40 μm). The boxed areas in b (i) and c (i) are magnified in b (ii) and c (ii) respectively. Error bars represent the SEM and P values are from Student's t -test. BMT, bone marrow transplantation.CC-BY-NC-ND · From the PDF
Figure 5 Quantification of chemokine/cytokines in the brains of busulfanand irradiation-conditioned transplant recipients. Cytometric Bead Array analysis demonstrated upregulation of MCP-1, MIP-1 A , and IL-1 A in busulfan-conditioned (Bu) and irradiated (Ir) brain compared with the wild-type controls ( P < 0.04; data not shown). 24 hours posttreatment, MCP-1 was significantly elevated in the serum of busulfan-conditioned recipients ( P < 0.04) and in irradiated brain ( P < 0.01); G-CSF was significantly elevated in busulfan-conditioned serum and brain ( P < 0.05); IL-1 A was significantly elevated in irradiated serum and brain and MIP-1 A was significantly elevated in irradiated brain ( P < 0.05; n = 7-8/group). At 6-9 months (long term), MCP-1 was significantly increased in busulfan-conditioned brain compared with the irradiated ( P < 0.002) and IL-1 A was significantly higher in irradiated brain ( P < 0.01; n = 2-4/group). Cytometric Bead Array analysis demonstrated upregulation of IL-6 in busulfan-conditioned brain ( P < 0.001) and RANTES and irradiated serum ( P < 0.001). KC, IL-1 B , IL-9, IL-13, IFNG , and GM-CSF were below the level of detection at both timepoints. Error bars represent the SEM and P values are from Student's ttest.
Figure 5 Quantification of chemokine/cytokines in the brains of busulfanand irradiation-conditioned transplant recipients. Cytometric Bead Array analysis demonstrated upregulation of MCP-1, MIP-1 A , and IL-1 A in busulfan-conditioned (Bu) and irradiated (Ir) brain compared with the wild-type controls ( P < 0.04; data not shown). 24 hours posttreatment, MCP-1 was significantly elevated in the serum of busulfan-conditioned recipients ( P < 0.04) and in irradiated brain ( P < 0.01); G-CSF was significantly elevated in busulfan-conditioned serum and brain ( P < 0.05); IL-1 A was significantly elevated in irradiated serum and brain and MIP-1 A was significantly elevated in irradiated brain ( P < 0.05; n = 7-8/group). At 6-9 months (long term), MCP-1 was significantly increased in busulfan-conditioned brain compared with the irradiated ( P < 0.002) and IL-1 A was significantly higher in irradiated brain ( P < 0.01; n = 2-4/group). Cytometric Bead Array analysis demonstrated upregulation of IL-6 in busulfan-conditioned brain ( P < 0.001) and RANTES and irradiated serum ( P < 0.001). KC, IL-1 B , IL-9, IL-13, IFNG , and GM-CSF were below the level of detection at both timepoints. Error bars represent the SEM and P values are from Student's ttest.CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 38

  1. Krause, 2001, Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell, Cell, 105, 369, 10.1016/S0092-8674(01)00328-2 · DOI
  2. Ajami, 2007, Local self-renewal can sustain CNS microglia maintenance and function throughout adult life, Nat Neurosci, 10, 1538, 10.1038/nn2014 · DOI · Paper page
  3. Priller, 2001, Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment, Nat Med, 7, 1356, 10.1038/nm1201-1356 · DOI · Paper page
  4. Chen, 2003, Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells, J Cereb Blood Flow Metab, 23, 748, 10.1097/01.WCB.0000071885.63724.20 · DOI
  5. Kuziel, 1997, Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2, Proc Natl Acad Sci USA, 94, 12053, 10.1073/pnas.94.22.12053 · DOI
  6. Liu, 2007, Origin of dendritic cells in peripheral lymphoid organs of mice, Nat Immunol, 8, 578, 10.1038/ni1462 · DOI
  7. Diserbo, 2002, Blood-brain barrier permeability after gamma whole-body irradiation: an in vivo microdialysis study, Can J Physiol Pharmacol, 80, 670, 10.1139/y02-070 · DOI
  8. Li, 2004, Early radiation-induced endothelial cell loss and blood-spinal cord barrier breakdown in the rat spinal cord, Radiat Res, 161, 143, 10.1667/RR3117 · DOI
  9. Kyrkanides, 2002, Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury, Brain Res Mol Brain Res, 104, 159, 10.1016/S0169-328X(02)00353-4 · DOI
  10. Linard, 2004, Acute induction of inflammatory cytokine expression after gamma-irradiation in the rat: effect of an NF-kappaB inhibitor, Int J Radiat Oncol Biol Phys, 58, 427, 10.1016/j.ijrobp.2003.09.039 · DOI
  11. Biffi, 2004, Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells, J Clin Invest, 113, 1118, 10.1172/JCI200419205 · DOI
  12. Langford-Smith, 2012, Hematopoietic stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA mice, Mol Ther, 20, 1610, 10.1038/mt.2012.82 · DOI
  13. Visigalli, 2010, Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model, Blood, 116, 5130, 10.1182/blood-2010-04-278234 · DOI
  14. Meng, 2003, Ionizing radiation and busulfan inhibit murine bone marrow cell hematopoietic function via apoptosis-dependent and -independent mechanisms, Exp Hematol, 31, 1348, 10.1016/j.exphem.2003.08.014 · DOI
  15. Probin, 2006, Busulfan selectively induces cellular senescence but not apoptosis in WI38 fibroblasts via a p53-independent but extracellular signal-regulated kinase-p38 mitogen-activated protein kinase-dependent mechanism, J Pharmacol Exp Ther, 319, 551, 10.1124/jpet.106.107771 · DOI
  16. Lampron, 2012, Effects of myeloablation, peripheral chimerism, and whole-body irradiation on the entry of bone marrow-derived cells into the brain, Cell Transplant, 21, 1149, 10.3727/096368911X593154 · DOI · Paper page
  17. Capotondo, 2012, Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation, Proc Natl Acad Sci USA, 109, 15018, 10.1073/pnas.1205858109 · DOI · Paper page
  18. Wake, 2009, Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals, J Neurosci, 29, 3974, 10.1523/JNEUROSCI.4363-08.2009 · DOI · Paper page
  19. Kanazawa, 2002, Macrophage/microglia-specific protein Iba1 enhances membrane ruffling and Rac activation via phospholipase C-gamma -dependent pathway, J Biol Chem, 277, 20026, 10.1074/jbc.M109218200 · DOI
  20. Streit, 1987, Lectin binding by resting and reactive microglia, J Neurocytol, 16, 249, 10.1007/BF01795308 · DOI
  21. Samlowski, 1989, Peripheral lymph node helper T-cell recovery after syngeneic bone marrow transplantation in mice prepared with either gamma-irradiation or busulfan, Blood, 74, 1436, 10.1182/blood.V74.4.1436.1436 · DOI
  22. Samlowski, 1987, Recovery of contact hypersensitivity responses following murine bone marrow transplantation: comparison of gamma-irradiation and busulfan as preparative marrow-ablative agents, Blood, 70, 1910, 10.1182/blood.V70.6.1910.1910 · DOI
  23. Thomas, 2002, Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor, Curr Opin Hematol, 9, 183, 10.1097/00062752-200205000-00002 · DOI
  24. Jopling, 2001, A cautionary tale: how to delete mouse haemopoietic stem cells with busulphan, Br J Haematol, 113, 970, 10.1046/j.1365-2141.2001.02825.x · DOI
  25. Bacigalupo, 2009, Defining the intensity of conditioning regimens: working definitions, Biol Blood Marrow Transplant, 15, 1628, 10.1016/j.bbmt.2009.07.004 · DOI
  26. Hess, 1996, Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy, Proc Natl Acad Sci USA, 93, 14821, 10.1073/pnas.93.25.14821 · DOI
  27. Kennedy, 1997, Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model, Blood, 90, 986, 10.1182/blood.V90.3.986 · DOI
  28. Allan, 2005, Interleukin-1 and neuronal injury, Nat Rev Immunol, 5, 629, 10.1038/nri1664 · DOI · Paper page
  29. Mihara, 2012, IL-6/IL-6 receptor system and its role in physiological and pathological conditions, Clin Sci, 122, 143, 10.1042/CS20110340 · DOI
  30. Hassan, 1992, In vivo distribution of [11C]-busulfan in cynomolgus monkey and in the brain of a human patient, Cancer Chemother Pharmacol, 30, 81, 10.1007/BF00686397 · DOI
  31. Soussain, 2009, CNS complications of radiotherapy and chemotherapy, Lancet, 374, 1639, 10.1016/S0140-6736(09)61299-X · DOI
  32. Bigger, 2006, Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX, Gene Ther, 13, 117, 10.1038/sj.gt.3302638 · DOI
  33. Siapati, 2007, Murine leukemia following irradiation conditioning for transplantation of lentivirally-modified hematopoietic stem cells, Eur J Haematol, 78, 303, 10.1111/j.1600-0609.2006.00813.x · DOI
  34. Siapati, 2005, Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells, Mol Ther, 12, 537, 10.1016/j.ymthe.2005.01.022 · DOI
  35. Okabe, 1997, ‘Green mice' as a source of ubiquitous green cells, FEBS Lett, 407, 313, 10.1016/S0014-5793(97)00313-X · DOI · Paper page
  36. Malinowska, 2010, Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease, PLoS ONE, 5, e14192, 10.1371/journal.pone.0014192 · DOI
  37. Canal, 2010, Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIB, Behav Brain Res, 209, 212, 10.1016/j.bbr.2010.01.045 · DOI
  38. Wilkinson, 2012, Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB, PLoS ONE, 7, e35787, 10.1371/journal.pone.0035787 · DOI

Cited by

See all 112

Metadata

Authors
Wilkinson, F. L., Sergijenko, A., Langford-Smith, K. J., Malinowska, M., Wynn, R. F., & Bigger, B. W.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2013-04
Volume
21
Issue
4
Pages
868-876
ISSN
1525-0016
Cited by
112
References
5
Language
en
Update notices
erratum (2013-07-01)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review